Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fruit and vegetables consumption and incident hypertension: dose-response meta-analysis of prospective cohort studies.

Journal of human hypertension·2016
Same author

The predictors of the severity of ischaemic colitis: a systematic review of 2823 patients from 22 studies.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2016
Same author

Economic Evaluation of Primary Prophylaxis Using Filgrastim Versus Pegfilgrastim in Patients With Solid Tumor Cancer: A Systematic Literature Review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

An Analysis of Pricing Premiums Granted Through Submitting Local RCT and Pharmacoeconomics Data in Taiwan.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

An Analysis of the Key Value Drivers for HTA Assessments In Taiwan.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

An Analysis of the Drivers of Pricing Premiums Granted to Innovative Products in Japan.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016

Related Experiment Video

Updated: Jul 6, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Immunological mechanisms in glaucoma.

F Grus1, D Sun

  • 1Experimental Ophthalmology, Department of Ophthalmology, University of Mainz, Mainz, Germany. grus@eye-research.org

Seminars in Immunopathology
|March 12, 2008
PubMed
Summary

Autoimmune mechanisms may play a role in glaucoma, a leading cause of blindness. Changes in autoantibody profiles against ocular antigens in glaucoma patients show potential for early disease detection.

Area of Science:

  • Ophthalmology
  • Immunology

Background:

  • Glaucoma is a primary cause of global blindness.
  • Elevated intraocular pressure is a risk factor but doesn't explain all cases.
  • Emerging evidence suggests autoimmune mechanisms contribute to glaucoma pathogenesis.

Purpose of the Study:

  • To review and demonstrate findings on autoimmune mechanisms in glaucoma patients.
  • To explore the role of autoantibodies in glaucoma development and detection.

Main Methods:

  • Review of existing literature on autoimmune markers in glaucoma.
  • Analysis of autoantibody profiles against ocular antigens in patient cohorts.

Main Results:

  • Glaucoma patients exhibit consistent alterations (up- and down-regulations) in autoantibody profiles.

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

Related Experiment Videos

Last Updated: Jul 6, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

  • These autoantibody changes are reproducible across independent study populations.
  • Conclusions:

    • Autoimmune processes are implicated in glaucoma.
    • Altered autoantibody profiles represent a potential biomarker for glaucoma detection.